...
机译:酪氨酸激酶抑制剂失败后,在非小细胞肺癌中进行扩增耐火突变体系,超扩增耐火突变体系和液滴数量PCR的比较
Department of Oncology Hangzhou First People’s Hospital Nanjing Medical University;
Hangzhou Translational Medicine Research Center Hangzhou First People’s Hospital Nanjing Medical;
Hangzhou Translational Medicine Research Center Hangzhou First People’s Hospital Nanjing Medical;
Hangzhou Translational Medicine Research Center Hangzhou First People’s Hospital Nanjing Medical;
Department of Oncology Hangzhou Cancer Hospital;
Department of Oncology Hangzhou First People’s Hospital Nanjing Medical University;
Department of Respiratory Hangzhou First People’s Hospital Nanjing Medical University;
Department of Thoracic Surgery Hangzhou First People’s Hospital Nanjing Medical University;
Hangzhou First People’s Hospital Nanjing Medical University;
T790?M; ctDNA; ARMS; ddPCR; SuperARMS; TKI resistance;
机译:酪氨酸激酶抑制剂治疗失败后非小细胞肺癌中T790ΔM突变检测的扩增难治性突变系统,超级扩增难治性突变系统和液滴数字PCR的比较
机译:酪氨酸激酶抑制剂失败后,在非小细胞肺癌中进行扩增耐火突变体系,超扩增耐火突变体系和液滴数量PCR的比较
机译:校正至:酪氨酸激酶抑制剂失败后,扩增耐火突变体系,超扩增耐火突变体系,超扩增耐火突变体系,超扩增耐火突变体系和液滴数码PCR在非小细胞肺癌中的突变检测
机译:接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
机译:ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
机译:液滴数字PCR和扩增难治性突变系统PCR检测肺癌无细胞DNA中EGFR突变的诊断准确性:一项荟萃分析
机译:非小细胞肺癌患者表皮生长因子受体突变直接测序和扩增难变突变体系